Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda, Laura Q.M. Chow, Elizabeth Claire Dees, Raanan Berger, Shilpa Gupta, Ravit Geva, Lajos Pusztai, Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, Vassiliki Karantza, Laurence Buisseret

View at source ↗Article1,477 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1200/jco.2015.64.8931
Published
May 2, 2016
Venue
Journal of Clinical Oncology
DOI
10.1200/jco.2015.64.8931
PubMed
27138582
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics